BLACKROCK ADVISORS LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 99 filers reported holding HERON THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$217,000
-26.9%
16,567
-4.0%
0.00%
Q3 2016$297,000
+8.8%
17,250
+14.2%
0.00%
Q2 2016$273,000
+7.9%
15,104
+13.3%
0.00%
Q1 2016$253,000
-40.7%
13,335
-16.5%
0.00%
Q4 2015$427,000
-6.8%
15,976
-14.8%
0.00%
Q3 2015$458,000
-9.3%
18,762
+15.7%
0.00%
-100.0%
Q2 2015$505,000
+173.0%
16,212
+27.5%
0.00%
Q1 2015$185,000
+71.3%
12,718
+18.6%
0.00%
Q4 2014$108,000
+40.3%
10,725
+16.1%
0.00%
Q3 2014$77,000
-23.0%
9,235
+13.3%
0.00%
Q2 2014$100,0008,1490.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders